Home > Products > CD20 & CD22
> Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scFv-CH1/CL)
Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-049)
Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD20 antibody variable domain is fused to CH1 and the other scFv from an anti-CD22 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scFv-CH1/CL) (BSCC-049). Click the button below to contact us or submit your feedback about this product.